Related Experiment Video

Updated: Aug 31, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

Retinopathy of prematurity

Kelly A Hutcheson1

  • 1Department of Ophthalmology, Childrens National Medical Center, Washington, DC 20010, USA.

Current Opinion in Ophthalmology
|September 23, 2003
PubMed

Insights

Recent advances in retinopathy of prematurity (ROP) research are reviewed. Key findings include new insights into ROP pathophysiology and anti-angiogenic treatments, alongside updated screening guidelines.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatric Medicine

Background:

  • Retinopathy of prematurity (ROP) remains a significant cause of visual impairment in premature infants.
  • Understanding the complex pathophysiology of ROP is crucial for effective management.

Purpose of the Study:

  • To review recent scientific and clinical advancements in retinopathy of prematurity (ROP).
  • To discuss novel therapeutic strategies and updated screening protocols for ROP.

Main Methods:

  • Literature review of recent basic science and clinical research on ROP.
  • Synthesis of findings from major clinical trials and studies on anti-angiogenic agents.
  • Analysis of current and proposed ROP screening criteria, including telephotoscreening.

Main Results:

  • Modern understanding of ROP pathophysiology has evolved, incorporating new insights into vascular development and injury.
  • Anti-angiogenic agents show promise as a treatment modality for ROP, with large clinical trials providing key efficacy and safety data.
  • Current ROP screening guidelines are effective, but potential modifications and the role of telephotoscreening are being explored to improve accessibility and efficiency.

Conclusions:

  • Retinopathy of prematurity presents ongoing challenges in pediatric ophthalmology.
  • Continued research into pathophysiology and treatment is essential for improving outcomes.
  • Optimizing screening strategies, including telemedicine, can enhance early detection and intervention for ROP.
Abstract

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Transcutaneous Microcirculatory Imaging in Preterm Neonates06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
The Retina01:32

The Retina

The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...